Four and a half years ago, Schering-Plough was struggling to deal with declining sales and earnings as well as legal and regulatory challenges. Desperately in need of new direction, it found its saviour in Fred Hassan.
Beverly Lybrand, Vice President of the HPV Franchise and Gardasil at Merck, explains why the human papillomavirus (HPV) preventative vaccine Gardasil is still picking up steam.
Dr. Richard Hargreaves, Vice President for Imaging and Dr. Alan Sachs, Vice President of RNA Therapeutics for Merck Research Laboratories talk to NGP about new breakaway technologies at Merck Research Laboratories.
By Eiry Roberts, Vice President of Project/Program Medical, Eli Lilly
Opportunity and hope. Those two words formed the framework of the 2007 annual North American Sales Meeting of Konica Minolta Business Solutions U.S.A., Inc., in New Orleans earlier this year.